 |
|
|
|
|
Joachim M. Greuel, Ph.D., MBA (Partner and Founder)
|
|
|
|
Dr. Joachim M. Greuel is founding and managing partner of Bioscience Valuation (German and US offices) and of Bioscience Market Research LCC in Boston (USA). Joachim supports private and public biotech companies in Europe and in the USA to communicate their value propositions and to close financing rounds successfully.
He assists clients in structuring and negotiating value-maximizing licensing agreements, in managing R&D risks and in analyzing and understanding a product's commercial potential long before it reaches the market. In this context Joachim pioneered new concepts in pharmaceutical market research including Target Profile Conjoint Analysis (TPCPSM) and Dynamic Market Modeling (DMMSM). Furthermore, Joachim serves as an advisor to biotechnology investment funds and trains senior pharma & biotech executives, venture capitalists and investment bankers in advanced valuation techniques.
Joachim began his professional career as head of a research team at Bayer AG (Germany). After his business education he joined the strategic services practice of Andersen Consulting (Switzerland and Germany). Before founding Bioscience Valuation Joachim was investment manager at New Medical Technologies, a Swiss venture capital fund.
Joachim studied biology in Marburg (Germany) and Cambridge (UK) and received his Ph.D. summa cum laude from the Max Planck Institute for Brain Research in Frankfurt (Germany). He holds an MBA with a finance and health care focus from the Wharton School of the University of Pennsylvania (USA). Joachim is a member of the ‘American Finance Association’ and of the ‘Institute for Operations Research and the Management Sciences’ (Baltimore, USA).
 Team overview
|
|
